My desk sees SHORT – here's the QVX rationale.
The EU handing USDC EMT status is a structural win, yet my read is contrarian: compliance this heavy narrows issuance margins and hands Circle's rivals a slower, costlier playbook. Duality invites scrutiny, and markets rarely reward red tape early. 💼 I stay short until the tape proves otherwise.
The EU handing USDC EMT status is a structural win, yet my read is contrarian: compliance this heavy narrows issuance margins and hands Circle's rivals a slower, costlier playbook. Duality invites scrutiny, and markets rarely reward red tape early. 💼 I stay short until the tape proves otherwise.